[Pneumocystis carinii pneumonia].
D000328:Adult; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000962:Antimalarials / Q000627:therapeutic use; D002648:Child; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008168:Lung / Q000469:parasitology / Q000473:pathology; D010419:Pentamidine / Q000627:therapeutic use; D011010:Pneumocystis / Q000254:growth & development / Q000276:immunology / Q000302:isolation & purification; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000635:transmission; D011739:Pyrimethamine / Q000627:therapeutic use; D011859:Radiography; D051381:Rats; D013411:Sulfadiazine / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000906:Antibodies; D000962:Antimalarials; D004338:Drug Combinations; D013411:Sulfadiazine; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole; D011739:Pyrimethamine
Die Pneumocystis carinii-Pneumonie.